CN1298724A - Medicine for treating immunodefiiciency disease - Google Patents
Medicine for treating immunodefiiciency disease Download PDFInfo
- Publication number
- CN1298724A CN1298724A CN 00132658 CN00132658A CN1298724A CN 1298724 A CN1298724 A CN 1298724A CN 00132658 CN00132658 CN 00132658 CN 00132658 A CN00132658 A CN 00132658A CN 1298724 A CN1298724 A CN 1298724A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- medicine
- herba
- isatidis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims description 19
- 201000010099 disease Diseases 0.000 title description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 5
- 229940079593 drug Drugs 0.000 title description 4
- 238000011282 treatment Methods 0.000 claims description 8
- 241000208340 Araliaceae Species 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 6
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 208000029462 Immunodeficiency disease Diseases 0.000 claims description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 239000010231 banlangen Substances 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000008517 radix Trichosanthis Substances 0.000 claims description 6
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 4
- 208000030507 AIDS Diseases 0.000 abstract description 20
- 208000011580 syndromic disease Diseases 0.000 abstract description 10
- 241000282414 Homo sapiens Species 0.000 abstract description 3
- 239000003440 toxic substance Substances 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 230000036737 immune function Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 241001633583 Adenophora Species 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 231100000167 toxic agent Toxicity 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000003723 Smelting Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A traditional Chinese medicinal preparation called "ai er kang" for treating the acquired immune deficiency syndrome (AIDS) is prepared from radix rehmanniae, adenophora, radix bupleuri, gynostemma pentaphylla, calculus bovis, etc., it possesses the functions of clearing away heat and toxic substance, promoting blood circulation and eliminating statis, raising comprehensive immune function of human body, etc..
Description
The present invention relates to a kind of medicine for the treatment of immunodeficiency diseases.Be raw material specifically with the natural Chinese medicines decoction pieces, the refining Chinese patent medicine preparation that is used for treating acquired immune deficiency syndrome (AIDS) specially " Ai Erkang " that forms.
Acquired immune deficiency syndrome (AIDS) from the beginning of the eighties since the U.S. is found, its M ﹠ M all rises with surprising rapidity year by year, at global rapid spread, though humanly have recognized that acquired immune deficiency syndrome (AIDS) is the acquired immune deficiency syndrome (AIDS) that is caused by cellular immunity deficiency.But because its paathogenic factor is not understood as yet, so this disease can not effectively be prevented and treat, at the higher South Africa Region of sickness rate, infection rate is up to 20%-30%, it is a kind of new human lethal infectious disease, human beings'health and existence in serious threat, but present not effective in cure as yet definite medicine.
To the at present antiviral chemotherapy that adopt of the treatment of acquired immune deficiency syndrome (AIDS) more, reverse transcriptase inhibitors, symptomatic treatments such as protease inhibitor, the natural drug treatment has also been adopted in some areas, but curative effect is extremely undesirable.Also lack the medicine that effectively to treat acquired immune deficiency syndrome (AIDS) in the market.
The object of the present invention is to provide a kind of easy to usely, determined curative effect can be repaired ruined immunologic function effectively, makes it to be tending towards normal new type natural pharmaceutical preparation.
Solution of the present invention is in the Southern Africa this disease have been carried out field research, with theory of Chinese medical science this sick pathogeny has been carried out extensive discussion, and carried out on the basis of a large amount of clinical trials, filter out and have the YIN nourishing removing heat from blood, heat-clearing and toxic substances removing, benefiting qi and nourishing blood, 32 kinds of the natural drug decoction pieces of multiple efficacies such as blood circulation promoting and blood stasis dispelling, kidney tonifying primordial qi strengthening, with refining pill or the oral liquid formulations of forming of conventional method, make its performance QI and blood regulating, tonifying vital QI, nourishing YIN for suppressing the hyperactive YANG, the effect of heat-clearing and toxic substances removing is to reach the purpose of effective treatment acquired immune deficiency syndrome (AIDS).Medicine of the present invention is made by following component:
Radix Astragali 10g-80g Radix Angelicae Sinensis 10g-60g Radix Adenophorae (Radix Glehniae) 10g-80g Radix Rehmanniae 30g-120g
Flos Lonicerae 30g-120g Folium Isatidis 10g-30g Radix Isatidis 10g-30g Radix Ginseng 10g-30g
Herb Gynostemmae Pentaphylli 10g-30g Radix Glycyrrhizae 10g-30g Rhizoma Pinelliae 10g-20g Radix Scutellariae 10g-30g
Radix Bupleuri 10g-30g Cortex Phellodendri 10g-30g Herba Houttuyniae 20g-40g Herba Artemisiae Scopariae 20g-40g
Radix Tripterygii Wilfordii 6g-20g Rhizoma Dioscoreae Nipponicae 10g-40g 20g-40g Radix Ophiopogonis Fructus Schisandrae Chinensis 10g-20g
Rhizoma Smilacis Glabrae 30g-90g Rhizoma Atractylodis Macrocephalae 20g40g Radix Trichosanthis 20g-40g Nidus Vespae 10g-30g
Rhizoma Chuanxiong 10g-30g Poria 10g-30g Herba Epimedii 10g-30g Calculus Bovis 3g-10g
The formula optimization weight proportion scope that Cornu Bubali powder 10g-30g Rhizoma Alismatis 10g-30g Cortex Moutan 10g-30g Rhizoma Dioscoreae 20g-40g prepares medicine of the present invention is:
Radix Astragali 30g-60g Radix Angelicae Sinensis 30g-60g Radix Adenophorae (Radix Glehniae) 30g-60g Radix Rehmanniae 90g-120g
Flos Lonicerae 60g-90g Folium Isatidis 20g-30g Radix Isatidis 10g-30g Radix Ginseng 15g-30g
Herb Gynostemmae Pentaphylli 20g-30g Radix Glycyrrhizae 20g-30g Rhizoma Pinelliae 10g-15g Radix Scutellariae 10g-20g
Radix Bupleuri 10g-20g Cortex Phellodendri 10g-20g Herba Houttuyniae 20g-30g Herba Artemisiae Scopariae 20g-30g
Radix Tripterygii Wilfordii 10g-15g Rhizoma Dioscoreae Nipponicae 15g-30g 20g-30g Radix Ophiopogonis Fructus Schisandrae Chinensis 10g-15g
Rhizoma Smilacis Glabrae 30g-60g Rhizoma Atractylodis Macrocephalae 20g-30g Radix Trichosanthis 20g-30g Nidus Vespae 20g-30g
Rhizoma Chuanxiong 10g-20g Poria 10g-30g Herba Epimedii 10g-20g Calculus Bovis 3g-6g
The optimum weight proportioning that Cornu Bubali powder 10g-20g Rhizoma Alismatis 10g-20g Cortex Moutan 10g-20g Rhizoma Dioscoreae 20g-30g prepares medicine of the present invention is:
Radix Astragali 45g Radix Angelicae Sinensis 30g Radix Adenophorae (Radix Glehniae) 40g Radix Rehmanniae 90g
Flos Lonicerae 90g Folium Isatidis 30g Radix Isatidis 30g Radix Ginseng 20g
Herb Gynostemmae Pentaphylli 30g Radix Glycyrrhizae 20g Rhizoma Pinelliae 20g Radix Scutellariae 20g
Radix Bupleuri 15g Cortex Phellodendri 15g Herba Houttuyniae 30g Herba Artemisiae Scopariae 30g
Radix Tripterygii Wilfordii 15g Rhizoma Dioscoreae Nipponicae 20g 30g Radix Ophiopogonis Fructus Schisandrae Chinensis 10g
Rhizoma Smilacis Glabrae 60g Rhizoma Atractylodis Macrocephalae 30g Radix Trichosanthis 25g Nidus Vespae 25g
Rhizoma Chuanxiong 15g Poria 20g Herba Epimedii 15g Calculus Bovis 6g
Cornu Bubali powder 20g Rhizoma Alismatis 15g Cortex Moutan 15g Rhizoma Dioscoreae 20g
With above-mentioned each component medicine according to a conventional method, can make the medicine " Ai Erkang " that the present invention treats immunodeficiency diseases.
The present invention develops in my clinical practice surplus 20 year, be used for treating on the basis of " immunologic balance therapy " of immune dysfunction, pass through in the Southern Africa the clinical observation of acquired immune deficiency syndrome (AIDS), with the theory of Chinese medical science is guidance, based on clinical dialectical, through a large amount of clinical experiments, constantly perfect improvement forms.Its characteristics are that it is the pure natural medical preparation, and determined curative effect has no side effect.Based on " Ai Erkang ", cooperate smelting to treat the medicine of opportunistic infection, simultaneous elimination and reinforcement, treating both the principal and the secondary aspects of a disease at the same time can make patient's clinical symptoms improve rapidly, obviously improves body resistance against diseases, is the medicine that acquired immune deficiency syndrome (AIDS) is treated in a kind of comparatively ideal smelting.
Claims (3)
1. medicine " Ai Erkang " for the treatment of immunodeficiency diseases is characterized in that it is the medicament of being made by the following weight proportion raw material:
Radix Astragali 10g-80g Radix Angelicae Sinensis 10g-60g Radix Adenophorae (Radix Glehniae) 10g-80g Radix Rehmanniae 30g-120g
Flos Lonicerae 30g-120g Folium Isatidis 10g-30g Radix Isatidis 10g-30g Radix Ginseng 10g-30g
Herb Gynostemmae Pentaphylli 10g-30g Radix Glycyrrhizae 10g-30g Rhizoma Pinelliae 10g-20g Radix Scutellariae 10g-30g
Radix Bupleuri 10g-30g Cortex Phellodendri 10g-30g Herba Houttuyniae 20g-40g Herba Artemisiae Scopariae 20g-40g
Radix Tripterygii Wilfordii 6g-20g Rhizoma Dioscoreae Nipponicae 10g-40g 20g-40g Radix Ophiopogonis Fructus Schisandrae Chinensis 10g-20g
Rhizoma Smilacis Glabrae 30g-90g Rhizoma Atractylodis Macrocephalae 20g-40g Radix Trichosanthis 20g-40g Nidus Vespae 10g-30g
Rhizoma Chuanxiong 10g-30g Poria 10g-30g Herba Epimedii 10g-30g Calculus Bovis 3g-10g
Cornu Bubali powder 10g-30g Rhizoma Alismatis 10g-30g Cortex Moutan 10g-30g Rhizoma Dioscoreae 20g-40g
2. according to the medicine " Ai Erkang " of claim 1 described treatment immunodeficiency diseases, wherein the mixing ratio by weight of each raw material is:
Radix Astragali 30g-60g Radix Angelicae Sinensis 30g-60g Radix Adenophorae (Radix Glehniae) 30g-60g Radix Rehmanniae 90g-120g
Flos Lonicerae 60g-90g Folium Isatidis 20g-30g Radix Isatidis 10g-30g Radix Ginseng 15g-30g
Herb Gynostemmae Pentaphylli 20g-30g Radix Glycyrrhizae 20g-30g Rhizoma Pinelliae 10g-15g Radix Scutellariae 10g-20g
Radix Bupleuri 10g-20g Cortex Phellodendri 10g-20g Herba Houttuyniae 20g-30g Herba Artemisiae Scopariae 20g-30g
Radix Tripterygii Wilfordii 10g-15g Rhizoma Dioscoreae Nipponicae 15g-30g 20g-30g Radix Ophiopogonis Fructus Schisandrae Chinensis 10g-15g
Rhizoma Smilacis Glabrae 30g-60g Rhizoma Atractylodis Macrocephalae 20g-30g Radix Trichosanthis 20g-30g Nidus Vespae 20g-30g
Rhizoma Chuanxiong 10g-20g Poria 10g-30g Herba Epimedii 10g-20g Calculus Bovis 3g-6g
Cornu Bubali powder 10g-20g Rhizoma Alismatis 10g-20g Cortex Moutan 10g-20g Rhizoma Dioscoreae 20g-30g
3. according to the medicine " Ai Erkang " of claim 1 described treatment immunodeficiency diseases, wherein the weight proportion of each raw material is:
Radix Astragali 45g Radix Angelicae Sinensis 30g Radix Adenophorae (Radix Glehniae) 40g Radix Rehmanniae 90g
Flos Lonicerae 90g Folium Isatidis 30g Radix Isatidis 30g Radix Ginseng 20g
Herb Gynostemmae Pentaphylli 30g Radix Glycyrrhizae 20g Rhizoma Pinelliae 10g Radix Scutellariae 15g
Radix Bupleuri 15g Cortex Phellodendri 15g Herba Houttuyniae 30g Herba Artemisiae Scopariae 30g
Radix Tripterygii Wilfordii 15g Rhizoma Dioscoreae Nipponicae 20g 30g Radix Ophiopogonis Fructus Schisandrae Chinensis 10g
Rhizoma Smilacis Glabrae 60g Rhizoma Atractylodis Macrocephalae 30g Radix Trichosanthis 25g Nidus Vespae 25g
Rhizoma Chuanxiong 15g Poria 20g Herba Epimedii 15g Calculus Bovis 6g
Cornu Bubali powder 20g Rhizoma Alismatis 15g Cortex Moutan 15g Rhizoma Dioscoreae 20g
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00132658 CN1298724A (en) | 2000-11-21 | 2000-11-21 | Medicine for treating immunodefiiciency disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00132658 CN1298724A (en) | 2000-11-21 | 2000-11-21 | Medicine for treating immunodefiiciency disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1298724A true CN1298724A (en) | 2001-06-13 |
Family
ID=4595299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00132658 Pending CN1298724A (en) | 2000-11-21 | 2000-11-21 | Medicine for treating immunodefiiciency disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1298724A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003013567A1 (en) * | 2001-08-09 | 2003-02-20 | Chinese Herbal Usa, Inc. | Compositions for the treatment of acquired immunodeficiency disease |
| CN100444859C (en) * | 2004-11-04 | 2008-12-24 | 苗毅韧 | Detoxifying, health-preserving, immunity-improving Chinese medicinal formulation and preparation method |
| CN100448470C (en) * | 2003-10-31 | 2009-01-07 | 财团法人工业技术研究院 | A pharmaceutical composition for relieving and treating allergic asthma, and its preparation method |
| CN100482262C (en) * | 2000-12-14 | 2009-04-29 | 顺天堂药厂股份有限公司 | Herbal pharmaceutical compositions for treating immun logical disorders |
| CN102940720A (en) * | 2012-11-22 | 2013-02-27 | 山东省立医院 | Anti-hepatoma traditional Chinese medicine compound preparation |
| CN103055205A (en) * | 2012-11-11 | 2013-04-24 | 新疆维吾尔自治区中医药研究院 | Heterophylla and astragalus mongholicus reinvigorating particle as well as preparation method and application thereof to preparation of medicament for treating acquired immune deficiency syndrome |
| CN108186946A (en) * | 2018-02-10 | 2018-06-22 | 郑小眼 | It is a kind of to treat AIDS skin system Chinese medicine composition |
-
2000
- 2000-11-21 CN CN 00132658 patent/CN1298724A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100482262C (en) * | 2000-12-14 | 2009-04-29 | 顺天堂药厂股份有限公司 | Herbal pharmaceutical compositions for treating immun logical disorders |
| WO2003013567A1 (en) * | 2001-08-09 | 2003-02-20 | Chinese Herbal Usa, Inc. | Compositions for the treatment of acquired immunodeficiency disease |
| CN100448470C (en) * | 2003-10-31 | 2009-01-07 | 财团法人工业技术研究院 | A pharmaceutical composition for relieving and treating allergic asthma, and its preparation method |
| CN100444859C (en) * | 2004-11-04 | 2008-12-24 | 苗毅韧 | Detoxifying, health-preserving, immunity-improving Chinese medicinal formulation and preparation method |
| CN103055205A (en) * | 2012-11-11 | 2013-04-24 | 新疆维吾尔自治区中医药研究院 | Heterophylla and astragalus mongholicus reinvigorating particle as well as preparation method and application thereof to preparation of medicament for treating acquired immune deficiency syndrome |
| CN102940720A (en) * | 2012-11-22 | 2013-02-27 | 山东省立医院 | Anti-hepatoma traditional Chinese medicine compound preparation |
| CN108186946A (en) * | 2018-02-10 | 2018-06-22 | 郑小眼 | It is a kind of to treat AIDS skin system Chinese medicine composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1100651A (en) | Chinese herbal prepn. for curing chronic gastroenteritis and peptic gastric ulcer | |
| CN1112201C (en) | Chinese medicine for curing hepatitis B and cirrhosis ascites | |
| CN1245707A (en) | Chinese medicine for curing AIDS and carcinomatosis | |
| CN103638370A (en) | Traditional Chinese medicine for treating dental ulcer | |
| CN103341079B (en) | Chinese medicine composition for treating acne | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN1298724A (en) | Medicine for treating immunodefiiciency disease | |
| CN1060953C (en) | Medicine for curing psoriasis | |
| CN102335336A (en) | Traditional Chinese medicine for treating lupus sebaceus | |
| CN1218706C (en) | Hepatitis B treaitng pill | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN1057230C (en) | Traditional Chinese medicine capsule for treating thrombophlebitis | |
| CN1095287A (en) | Abdominal protecting medicine for external use | |
| CN103611100A (en) | Traditional Chinese medicine for treating toothaches | |
| CN1931329A (en) | Stomatocase treating medicine | |
| CN1365822A (en) | 'Shugan Lidan' capsule and its preparing process | |
| CN1128154A (en) | Medicine for treating hyperosteogenia | |
| CN1210005A (en) | Medicine for necrosis of femoral head | |
| CN105641128A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN1322558A (en) | an anti-cancer drug | |
| CN1055014C (en) | Medicine powder for curing hepatitis B | |
| CN1249191A (en) | Powdered medicine for treating vasculitis and its preparing process | |
| CN1057912C (en) | "Danshenye" Chinese medicinal liquid for treatment of cholecystitis | |
| CN1058622C (en) | Rehabilitation powder for hepatitis B | |
| CN103028058B (en) | Traditional Chinese medicine composition for treating feebleness |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Li Jiayang Document name: Notification before expiration of term |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Li Jiayang Document name: Deemed as a notice of withdrawal |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Li Jiayang Document name: Deemed as a notice of withdrawal |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |